V[irtually]{.smallcaps} all eukaryotic cells contain mitochondria, which produce most of the ATP cells need to grow and divide. Both mitochondrial shape and mitochondrial distribution can be tailored to meet the specialized energy requirements of a cell. In muscle fibers, for example, mitochondria are organized into regular columns stacked between actin-myosin bundles ([@B3]). During spermatogenesis in insects, mitochondria fuse into a few large organelles that later extend along the length of the growing flagellum ([@B18]). Many other cell types contain a reticulum of interconnected, tubular mitochondrial membranes that are spread throughout the cytoplasm ([@B5]; [@B6]). The molecular mechanisms required to generate and/or maintain these diverse mitochondrial morphologies and distributions are not well understood.

The budding yeast *Saccharomyces cerevisiae* contains a branched network of mitochondrial tubules that are located near the plasma membrane and are distributed evenly in the peripheral cytoplasm (for review see [@B24]). Maintenance of this tubular network requires interactions between the mitochondrial compartment and cytoskeletal structures, including actin ([@B33]; [@B54]; [@B25]) and intermediate filaments ([@B35]). Two mitochondrial outer membrane proteins, Mmm1p (*mmm*,^1^ [m]{.ul}itochondrial [m]{.ul}orphology [m]{.ul}aintenance; [@B10]) and Mdm10p (*mdm*, [m]{.ul}itochondrial [d]{.ul}istribution and [m]{.ul}orphology; [@B55]), appear to mediate the attachment of mitochondria to actin filaments ([@B8]), and in strains lacking these or another membrane protein called Mdm12p ([@B7]), the mitochondrial network is converted into giant, spherical organelles. Two other outer membrane proteins, the dynamin-related GTPase Mgm1p (*mgm*; [m]{.ul}itochondrial [g]{.ul}enome [m]{.ul}aintenance) and the transmembrane GTPase Fzo1p (*fzo*; [f]{.ul}u[z]{.ul}zy [o]{.ul}nions), also regulate mitochondrial morphology. The function of Mgm1p is not known, but cells lacking this protein contain severely aggregated mitochondrial membranes ([@B30]; [@B21]; Shepard, K.A., and M.P. Yaffe. 1997. *Mol. Biol. Cell*. 8:444a; Gorsich, S., and J.M. Shaw, unpublished). The Fzo1p GTPase regulates mitochondrial fusion, and loss of Fzo1p function causes the mitochondrial network to rapidly fragment ([@B26]).

We previously reported the isolation of a collection of *mdm* mutants with defective mitochondrial distribution and morphology ([@B25]). In one of these strains, *mdm29-1*, the mitochondrial network collapses to one side of the cell, forming an elongated mass of mitochondrial membranes that function normally, retain their mtDNA, and are efficiently transported into buds during division. *MDM29* is identical to *DNM1* and encodes one of three dynamin-related proteins in yeast ([@B19]). The dynamins comprise a family of high--molecular weight GTPases that localize to a variety of different cellular structures ([@B12]; [@B60]; [@B16]; [@B34]; [@B68]; [@B48]; [@B59]). Mammalian dynamin is the best characterized of the family members and has been shown to assemble into collars around the base of clathrin-coated pits ([@B58]). Subsequent GTP hydrolysis by dynamin in these collars is thought to stimulate a membrane scission activity that releases endocytic vesicles ([@B27]; [@B61]; [@B13], [@B14]; [@B28]; [@B58]; [@B57]). The yeast Dnm1 protein (Dnm1p) was originally thought to be the homologue of mammalian dynamin. However, mutations in *DNM1* do not block endocytosis of pheromone receptors in *Saccharomyces cerevisiae* ([@B19]). In addition, *dnm1* mutations do not affect other cellular transport pathways, including the secretory pathway and the vacuole protein sorting pathway. Thus, the exact function of Dnm1p in vivo is unclear.

In this report, we present evidence that Dnm1p controls the morphology and cortical distribution of yeast mitochondrial membranes. Mutational analysis reveals that the predicted GTPase domain of Dnm1p is required for its activity in vivo. In wild-type cells, the Dnm1 protein is found in patches distributed uniformly at the cell cortex that colocalize with the mitochondrial network. These Dnm1p-containing structures could regulate mitochondrial branching or division, or could act as attachment sites to distribute the mitochondrial network evenly at the cell periphery.

Materials and Methods {#MaterialsMethods}
=====================

Yeast Methods
-------------

Standard methods were used for growth, transformation, and genetic manipulation of *S*. *cerevisiae*. Rich medium (YP-Dextrose and YP-Glycerol), synthetic medium (synthetic dextrose \[SD\] and synthetic galactose \[SGal\]) and medias containing 5-fluoro-orotic acid (5-FOA) were prepared as described ([@B52]).

Strains
-------

*Escherichia coli* strains DH5α and JM109 (Promega Corp., Madison, WI) were used for bacterial manipulations of clones and plasmids. Yeast strains used in this study are listed in Table [I](#TI){ref-type="table"}. JSY1542 (containing genomic *DNM1-HA[~c~]{.smallcaps}*) was generated by integrating a 3×HA-*URA3*-3×HA (hemagglutinin) cassette between codons 756 and 757 of the *DNM1* coding region in JSY1539 ([@B49]). Cells that had undergone recombination and loss of the *URA3* portion of the cassette were selected by growth on 5-FOA (confirmed by PCR). The resulting JSY1542 strain expresses a full-length Dnm1 protein containing 3×HA epitopes inserted in-frame before the last amino acid of the polypeptide chain (confirmed by Western blotting with a polyclonal anti-HA antibody; Berkeley Antibody Company, Richmond, CA). JSY1678 (containing genomic *GAL1-DNM1*) was also generated by integrating a *GAL1-URA3-GAL1* cassette upstream of the *DNM1* coding region in JSY1238 ([@B49]) and selecting for *URA3* loss on 5-FOA. The genomic region corresponding to −100 bp to −10 bp upstream of the start codon is replaced by the *GAL1* promoter.

Plasmids
--------

pRS415-*DNM1* (pDO7) contains the *DNM1* coding region flanked by 419 bp of upstream and 401 bp of downstream sequence and was prepared by cloning a PCR product into the BamHI site of pRS415 (*CEN*, *LEU2*; Stratagene, La Jolla, CA). The region of the plasmid containing *DNM1* was sequenced. pRS425-*DNM1* (pDO13) was constructed by cloning the BamHI fragment from pRS415-*DNM1* into BamHI-digested pRS425 (2 micron, *LEU2*; Stratagene). pYEp213-*DNM1* was constructed by cloning the BamHI fragment from pRS415-*DNM1* into BamHI-digested pYEp213 (2 micron, *LEU2*). pRU1-*DNM1* and pRL1-*DNM1* were constructed by cloning the BamHI fragment from pRS415-*DNM1* into BamHI-digested pRU1 and pRL1, respectively (see below). All of the plasmids described above complemented the mitochondrial morphology defect in the *dnm1* null strain JSY1361 (see Table [I](#TI){ref-type="table"}).

Plasmids derived from the YCp50 ([@B47]) and p366 (P. Hieter, Johns Hopkins University, Baltimore, MD) shuttle vectors were modified to remove the unique BglII site in ARS1. YCp50 (*CEN URA3*) and p366 (*CEN LEU2*) were digested with BglII, end-filled to create blunt ends, and ligated to recircularize the vectors (a new ClaI site is created in the ligated vectors). The resulting plasmids were named pRhino*URA3*/1 (pRU1) and pRhino*LEU2*/1 (pRL1). These plasmids are maintained at low copy in both *E*. *coli* and yeast.

In some experiments, strains were transformed with the plasmid pDO10 to visualize mitochondrial compartments labeled with Cox4--GFP (green fluorescent protein). To construct pDO10, a NotI-XhoI restriction fragment from pOK29 (containing the mitochondrial targeting sequence of Cox4p fused in-frame to the NH~2~ terminus of GFP; provided by R. Jensen) was ligated into pRS415 (*LEU2*).

Mapping of the mdm29-1 Mutation to the DNM1 Locus
-------------------------------------------------

Genetic mapping of *mdm29* was carried out in several steps. First, *mdm29-1* was crossed to strains containing *trp1* mutant alleles. Analysis of tetrads derived from this cross indicated that *mdm29-1* was centromere-linked (1.35 cM, 37 tetrads). Second, *mdm29-1* was localized to chromosome XII (linked to the asp5/aat2 locus; 14.29 cM, 28 tetrads) in crosses with a collection of mapping strains obtained from the American Type Culture Collection (Rockville, MD). Third, complementation analysis was performed by crossing *mdm29-1* with strains harboring mutations in genes close to the centromere on chromosome XII. Subsequent studies showed that the mitochondrial morphology defect observed in *mdm29-1* was not complemented in a diploid heterozygous for mutations in *mdm29-1* and *dnm1* (MS3031; [@B19]). Meiotic segregation analysis with the *mdm29-1/dnm1* diploid confirmed that *mdm29-1* was closely linked to *dnm1*. The *dnm1* null strain (MS3031) from the Rose laboratory exhibited mitochondrial morphology defects similar to those observed in the *mdm29* mutant. Plasmids pDO7 and pDO13 (see above) containing the wild-type *DNM1* gene fully complement the mitochondrial morphology defects observed in the *mdm29-1* and *dnm1* null mutant strains.

Sequencing of mdm29 Mutant Alleles and Disruption of MDM29/DNM1
---------------------------------------------------------------

Overlapping segments of the *DNM1* gene were PCR amplified from yeast genomic DNAs prepared from the *MDM29*/*DNM1* (JSY1238), *mdm29-1* (JSY1236), and *mdm29-2* (JSY1943) strains. PCR products from triplicate reactions were pooled, purified (Qiagen, Chatsworth, CA), and sequenced on both strands (University of Utah Health Sciences Sequencing Facility). The wild-type *DNM1* gene sequence from the FY strain background was identical to the sequence reported in the *Saccharomyces* Genome Database (SGD). However, our *DNM1* sequence and the SGD *DNM1* sequence differed from that reported by [@B19]. Counting from the first (1) nucleotide of the methionine initiation codon, the sequence reported by [@B19] contains nine extra nucleotides (5′-TATCACCTG-3′) inserted between nucelotides 370 and 371 of the *DNM1* sequence. In addition, nucleotide 370, reported as A in the [@B19] sequence, is a C in our sequence and in the SGD. These changes alter the predicted amino acid sequence in this region from F^122^L[ISPD]{.ul}IPG to F^122^L[H]{.ul}IPG. All maps, plasmids, and strains used in this study contain the shorter *DNM1* sequence listed in the SGD.

A *dnm1* null mutation in the FY strain background ([@B70]) was generated by gene replacement using a PCR fragment containing the *HIS3* gene (pRS403; Stratagene) contiguous with *DNM1*-flanking sequences. The resulting *dnm1::HIS3* disruption (lacking all *DNM1* coding sequences) was confirmed by Southern blotting of genomic DNA isolated from a His^+^ transformant.

Site-directed Mutagenesis
-------------------------

A 3.1-kb fragment containing the *DNM1* coding region and flanking 5′ and 3′ sequence was subcloned into the BamHI site in the p-ALTER-1 vector (Promega Corp.). Site-directed mutagenesis was performed with oligonucleotides to generate the different point mutations as described by the manufacturer (Promega Corp.). The GTPase deletion construct was generated by adding a BglII site 1,014 nucleotides after the start codon. An additional BglII site is present in the wild-type *DNM1* sequence 15 nucleotides after the Dnm1p start codon. Subsequent BglII digestion/religation removed *DNM1* coding sequence corresponding to amino acids 8--338 and resulted in an in-frame fusion of sequences encoding amino acids 7--339 (GTPase deletion). Mutant *dnm1* sequences confirmed by restriction digest and sequence analysis were subcloned into pRU1 (described above) or YEp213 (*LEU2*) and introduced into JSY1238 (wild-type), JSY1361 (*dnm1Δ*), and JSY1678 (*GAL1-DNM1*) strains. DNA sequencing and sequence analyses were performed as described for the *mdm29* mutant alleles.

The effect of the GTP domain mutations on mitochondrial morphology was examined in strains grown in synthetic dextrose medium lacking uracil (to maintain the low copy pRU1 *CEN* plasmid) or synthetic dextrose medium lacking leucine (to maintain the high copy YEp213 2μ plasmid). Overexpression of wild-type Dnm1p in the *GAL1-DNM1* strain was achieved by growing strains overnight in synthetic galactose medium lacking either uracil (pRU1) or leucine (YEp213).

Characterization of dnm1 Organellar Phenotypes
----------------------------------------------

To characterize mitochondrial distribution and morphology, wild-type and *dnm1* mutant cells were grown overnight in YPD or synthetic media at 30°C, diluted 1:10 in fresh media, and incubated at 30°C for an additional 3 h. 100 μl of culture was stained with 100 nM 3,3′ dihexyloxacarbocyanine (DiOC~6~) (Molecular Probes, Eugene, OR) as described previously ([@B25]; [@B43]). Alternatively, cells expressing the Cox4--GFP protein from the pOK29 or pDO10 plasmids were grown overnight under the same conditions and inspected microscopically. Mitochondrial morphology phenotypes were scored in *n* ≥ 100 cells in at least three independent experiments. Comparable results were obtained using both of these staining methods, indicating that the mitochondrial morphology phenotypes observed in *dnm1Δ* cells were not due to the presence of the Cox4--GFP fusion protein (see also [@B43]).

Rhodamine-phalloidin staining of actin ([@B25]; [@B43]), antitubulin staining ([@B40]), 4′,6-diamidino-2-phenylindole (DAPI) staining of nuclei and mtDNA ([@B25]), FM 4-64 staining of vacuoles and kinetic analysis of FM 4-64 internalization ([@B44]; [@B63]), anti-Kar2p indirect immunofluorescence of ER membranes ([@B51]), and Sec7p-EGFP staining of Golgi membranes ([@B50]; generously provided by O. Rossanese and B. Glick, University of Chicago, Chicago, IL) were performed as described.

Dnm1p Induction and Depletion Studies
-------------------------------------

To examine mitochondrial morphology changes during a Dnm1p induction time course, JSY1678 cells (harboring the genomic *GAL1-DNM1* gene) were grown in synthetic medium containing 2% dextrose for 16 h at 30°C to deplete the cells of the endogenous Dnm1 protein. After diluting and growing for an additional 3 h to obtain log phase cultures, the cells were pelleted, washed with dH~2~O, and resuspended in fresh synthetic medium containing 2% galactose to induce expression of the *GAL1-DNM1* gene. For the depletion time course, JSY1678 cells grown in synthetic medium containing 2% galactose for 16 h at 30°C were diluted into galactose-containing medium, grown to log phase, pelleted, washed in dH~2~O, and resuspended in synthetic dextrose-containing medium to turn off expression of the *GAL1-DNM1* gene. Mitochondrial morphology was scored in 100-μl aliquots of DiOC~6~-stained cells removed at various times after transfer to the new medium. The density of the culture was maintained between 0.5--2.0 OD~600~ units during the course of the experiment. In control experiments, cells containing the *DNM1* gene expressed from its own promoter (JSY1238) maintained wild-type mitochondrial networks throughout the same time course.

Protein extracts prepared from equivalent numbers of cells were analyzed by SDS-PAGE and Western blotting ([@B22]) using a 1:2,500 dilution of the affinity-purified rabbit polyclonal antiserum generated against the COOH terminus of Dnm1p (described below). To control for differences in protein loading, the blots were stripped and reprobed with an antibody to the cytosolic marker 3-PGK (Molecular Probes, Eugene, OR). Detection was carried out using ECL (NEN™ Life Science Products, Boston, MA). Densitometry (NIH Image software) was used to determine the level of Dnm1p expression from the *GAL1* promoter (JSY1678) relative to the endogenous *DNM1* promoter (JSY1238).

Generation of Affinity-purified Anti-Dnm1p Antibodies
-----------------------------------------------------

A 1-kb EcoRI fragment encoding the COOH-terminal amino acids 412-- 757 of Dnm1p was subcloned into the pGEX-2T (128/129) expression vector (M. Blanar, Bristol-Myers Squibb, Princeton, NJ) to create the pGEX-2T-DNM1-C plasmid. *E*. *coli* BL21-(DE3) cells containing pGEX-2T-DNM1-C express a 65-kD glutathione-S-transferase (GST)--Dnm1^412--757^ fusion protein, which was purified on Glutathione Sepharose 4B beads (Pharmacia Biotech, Piscataway, NJ), run on 8% SDS-PAGE gels, excised, and used to immunize rabbits (Berkeley Antibody Co.). Soluble Dnm1p fused to 6× HIS residues at the COOH terminus (pET23a-DNM1-3) was expressed in *E*. *coli* BL21-(DE3) cells, purified by affinity chromatography on His-Bind resin (Novagen, Inc., Madison, WI), and coupled to cyanogen bromide--activated Sepharose 4B as recommended by the manufacturer (Pharmacia Biotech). Rabbit polyclonal anti--GST-Dnm1^412--757^ fusion protein antibody was affinity purified on the Dnm1-6XHISp-Sepharose column, equilibrated in PBS, pH 7.2, concentrated to 0.35 mg/ml (using a Centricon-30 filter unit; Amicon Corp., Easton, TX), and stored at −80°C after addition of 5 mg/ml BSA (Fraction V; Sigma Chemical Co., St. Louis, MO).

Immunolocalization of the Dnm1-HA~C~ and Wild-Type Dnm1 Proteins
----------------------------------------------------------------

Indirect immunofluorescence was performed essentially as described ([@B44]) except that cells expressing Cox4--GFP (pDO10) were fixed in 4.4% formaldehyde for 2 h to preserve GFP fluorescence. To detect the HA epitope, cells were incubated with the following antibodies: (*a*) 1:1,000 dilution of a 1 mg/ml mouse monoclonal anti-HA antibody for 14 h (catalog No. MMS-101P-500; Berkeley Antibody Co.), (*b*) 1:10 dilution of a 2.4 mg/ml goat anti--mouse polyclonal antibody (catalog No. 115-005-003; Jackson ImmunoResearch, West Grove, PA), (*c*) 1:10 dilution of a 1.8 mg/ml mouse anti--goat polyclonal antibody (catalog No. 205-005-108; Jackson ImmunoResearch), and (*d*) 1:100 dilution of a 1.5 mg/ml CY5-conjugated goat anti--mouse polyclonal antibody (catalog No. 115-175-003; Jackson ImmunoResearch). To detect the wild-type Dnm1 protein (lacking the COOH-terminal HA epitope), cells were incubated with: (*a*) 1:50 dilution of the 0.345 mg/ml affinity-purified rabbit anti--GST-Dnm1^412--757^ antibody and (*b*) 1:25 dilution of a 1.5 mg/ml CY5-conjugated goat anti--rabbit polyclonal antibody (catalog No. 111-175-144; Jackson ImmunoResearch).

To quantify the degree of Dnm1p/mitochondrial colocalization, 1-μm optical sections were generated through fixed yeast cells costained for Dnm1p (CY5) and a mitochondrial matrix marker (Cox4--GFP). Three-dimensional projections of individual cells as well as separated and merged CY5 and Cox4--GFP fluorescence images were generated. Individual CY5 spots in 5--10 cells were scored relative to the GFP-stained mitochondrial network as localizing to a nonmitochondrial position or to the mitochondrial network, and the data were expressed as the percentage of total spots colocalizing with the mitochondrial network.

Differential Sedimentation and Sucrose Gradient Fractionation
-------------------------------------------------------------

Cells grown in SGal medium were fractionated by differential sedimentation as described previously ([@B15]; [@B72]; [@B26]), except that the P~10,000~ mitochondrial pellet was subjected to an additional wash step. In brief, P~10,000~ was resuspended in breaking buffer (0.6 M mannitol, 20 mM Hepes-KOH, pH 7.4, plus protease inhibitor cocktail), and spun at 1,500 *g* for 5 min to yield P~1,500~ and S~1,500~. S~1,500~ was spun at 10,000 *g* for 10 min to yield a washed P~10,000~ pellet and a second S~10,000~ supernatant. Protein concentrations were determined using the Bio-Rad Protein Assay (Hercules, CA), and 2 μg of protein from each fraction was analyzed by Western blotting with the following antibody dilutions: anti-Dnm1p (1:5,000), antiporin (1:1,000; Molecular Probes), and anti--3-PGK (1:1,000; Molecular Probes).

The P~10,000~ mitochondrial pellet was subjected to sucrose gradient fractionation as described by [@B66]. The S~10,000~ supernatant was spun at 100,000 *g* for 1 h (model SW50.1 rotor; Beckman Instruments, Fullerton, CA) to generate S~100,000~ and P~100,000~ fractions. Equal volumes of gradient fractions or equal volumes of S~100,000~ and P~100,000~ fractions were assayed by Western blotting with the following antibody dilutions: anti-Dnm1p (1:1,000), antiporin (1:1,000), anti--3-PGK (1:1,000), anti-- Dol-P-Man Synthase (1:1,000), anti-Mnn1p (1:400), anti-ALP (1:1,000), and anti-Gas1p (1:5,000). Na~2~CO~3~ and Triton X-100 treatments of the P~10,000~ fraction were performed essentially as described ([@B26]).

Microscopy
----------

Organellar phenotypes were quantified with a microscope (model Axioplan; Carl Zeiss, Inc., Thornwood, NY) equipped with differential interference contrast optics, epifluorescence capabilities, and a 100× (NA 1.3) objective (model Acroplan-Neofluar; Carl Zeiss, Inc.). In some experiments, cells were viewed with a confocal microscope (model MRC-600; Bio-Rad Microsciences, Cambridge, MA; 1-μm optical serial sections) attached to a microscope (model Optiphot; Nikon, Inc., Melville, NY) equipped with a 60× plan apochromat objective (NA 1.3; Carl Zeiss, Inc.). Images were collected using Bio-Rad image capture software, and projections were generated using Confocal Assistant software (copyright by Todd Clark Brelje). Electron microscopy was performed as described ([@B26]).

Results {#Results}
=======

The Dynamin-like GTPase, Dnm1p, Is Required for the Maintenance of Mitochondrial Morphology in Yeast
----------------------------------------------------------------------------------------------------

The *mdm29-1* and *mdm29-2* mutations cause defective mitochondrial morphology in yeast. Genetic methods were used to map *mdm29* to a region close to the centromere of chromosome XII. Analysis of open reading frames near this centromere revealed that *mdm29* maps to a previously isolated gene called *DNM1*, one of three dynamin-related genes in yeast ([@B19]). Sequence analysis showed that the *mdm29-1* mutation causes a truncation after amino acid 120 within the conserved, NH~2~-terminal GTPase domain of the Dnm1 protein (Dnm1p). The *mdm29-2* allele introduces a stop codon that removes the COOH-terminal 26 amino acids of Dnm1p. We also generated a *dnm1* null allele by gene disruption (*dnm1Δ*). The phenotypes observed in *dnm1Δ* are identical to those found in *mdm29-1* and *mdm29-2*, suggesting that both mutant alleles result in a complete loss of Dnm1p function.

In *dnm1Δ* cells, the highly branched mitochondrial network observed in wild-type strains (Fig. [1](#F1){ref-type="fig"}, *Wildtype*) collapses to form a long tubular structure that is still localized to the cell cortex (Fig. [1](#F1){ref-type="fig"}, *dnm1Δ*). Staining with the DNA-specific dye DAPI ([@B40]) indicates that these elongated organelles contain mitochondrial DNA nucleoids (Fig. [2](#F2){ref-type="fig"} *D*). The mitochondrial phenotype caused by the *dnm1Δ* mutation is strikingly different from that caused by the previously isolated *mmm1*, *mdm10*, and *mdm12* mutations, which convert mitochondrial networks into one or a few large spherical organelles ([@B10]; [@B55]; [@B7]; for example see Fig. [12](#F12){ref-type="fig"} *G*).

Transmission electron microscopy confirmed that mitochondrial distribution and morphology were altered in the *dnm1Δ* strain (Fig. [3](#F3){ref-type="fig"}). In wild-type cells, mitochondrial tubules in cross section appeared uniform in size, were distributed evenly in the peripheral cytoplasm, and contained distinct cristae (invaginations of the inner mitochondrial membrane) (Fig. [3](#F3){ref-type="fig"} *A*). Although mitochondrial profiles in *dnm1Δ* cells contained normal cristae, the compartments often appeared as a series of larger tubules restricted to one half of the cell (Fig. [3](#F3){ref-type="fig"}, *B* and *C*). These mitochondrial tubules were usually interconnected or branched, indicating that *dnm1Δ* mitochondrial membranes still retain some features of a mitochondrial network or reticulum (Fig. [3](#F3){ref-type="fig"}, *B* and *C*) and had not fused to form a single, elongated mitochondrial compartment.

Despite their unusual morphology, a number of observations suggest that normal functions of *dnm1Δ* mitochondria are not severely compromised. First, the abnormal mitochondria in *dnm1Δ* cells are efficiently transported into buds during division (Fig. [1](#F1){ref-type="fig"}, *dnm1Δ*). Second, these mitochondria can be labeled with the potential-dependent dye DiOC~6~, which only stains actively respiring organelles ([@B40]). Third, a Cox4--GFP fusion protein (targeted to the matrix; generously provided by R. Jensen) also stains collapsed *dnm1Δ* mitochondria (Figs. [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}), indicating that the mitochondrial protein import machinery is not grossly affected. Fourth, in our strain background, cells harboring *dnm1* mutations grow as well as wild-type on the nonfermentable carbon sources glycerol, lactate, and ethanol/acetate, which can only be metabolized in cells with functional mitochondria. In addition, the organelle morphology defect in *dnm1Δ* cells appears specific for mitochondria and does not affect the morphology of other membrane-bound structures, including nuclei (Fig. [2](#F2){ref-type="fig"} *D*), the endoplasmic reticulum (Fig. [4](#F4){ref-type="fig"} *F*), the Golgi apparatus (Fig. [5](#F5){ref-type="fig"}, *C* and *D*), and vacuoles (Fig. [6](#F6){ref-type="fig"} *D*). In addition, indirect immunofluorescence studies indicate that the organization of the actin (Fig. [7](#F7){ref-type="fig"} *D*) and tubulin (Fig. [7](#F7){ref-type="fig"} *H*) cytoskeletons is not altered in *dnm1Δ*. Together, these results indicate that *DNM1* plays an important and specific role in generating and/or distributing the branched mitochondrial network in yeast.

Mitochondrial Morphology Changes Dramatically when Dnm1p Expression Is Induced or Repressed in Yeast Cells
----------------------------------------------------------------------------------------------------------

To further characterize the function of *DNM1* in vivo, we examined mitochondrial morphology in cells carrying only a chromosomal copy of *DNM1* under control of the *GAL1* promoter (JSY1678). When this strain is grown overnight in dextrose-containing medium (which represses transcription from the *GAL1* promoter), no Dnm1p can be detected (Fig. [8](#F8){ref-type="fig"} *B*, 0 min; *U*, undetected), and \>95% of the cells contain collapsed mitochondrial networks (Fig. [8](#F8){ref-type="fig"} *B*, *closed triangles*; and 8 *E*, *Null*). 15 min after transfer to galactose-containing medium to induce expression of Dnm1p, the percentage of cells in the population exhibiting the null mitochondrial morphology begins to decline, and cells containing a more branched "intermediate" morphology appear (Fig. [8](#F8){ref-type="fig"} *B*, *open squares*; and 8 *E*, *Intermediate*). As shown in the confocal microscope projections in Fig. [8](#F8){ref-type="fig"} *E*, cells with this intermediate morphology appear to be extending tubules of mitochondrial membrane around the cell periphery to form a ring. By 140 min, the tubules extended around the cortex begin forming additional branches characteristic of the wild-type mitochondrial network, and at later time points (200 min), virtually 100% of the cells in the population exhibit wild-type mitochondrial morphology (Fig. [8](#F8){ref-type="fig"} *B*, *closed circles*; and 8 *E*, *WT*). These changes in mitochondrial morphology are correlated with an increase in the intracellular level of the Dnm1 protein. As shown below the graph in Fig. [8](#F8){ref-type="fig"} *B*, the steady-state level of Dnm1p in the induced *GAL1-DNM1* strain increases from undetected (*U*, at time zero) to 1.1 (at 200 min) relative to the wild-type *DNM1* strain (containing a single chromosomal copy of the *DNM1* gene expressed from its own promoter). In control experiments, *DNM1* cells maintain wild-type mitochondrial networks throughout the same time course (Fig. [8](#F8){ref-type="fig"} *A*, *closed circles*).

We also found that the wild-type mitochondrial network collapses when cells are transferred from galactose to dextrose to turn off transcription of the *GAL1-DNM1* gene (Fig. [8](#F8){ref-type="fig"} *D*). In these experiments, \>95% of the cells grown in galactose medium contain highly branched, wild-type mitochondrial networks (Fig. [8](#F8){ref-type="fig"} *D*, *closed circles*; and 8 *E*, *WT*). Although the initial steady-state level of Dnm1p expressed from the chromosomal *GAL1-DNM1* construct is 1.9-fold higher than that observed in the wild-type *DNM1* strain (Fig. [8](#F8){ref-type="fig"} *D*, relative protein level at time zero), this level of Dnm1p overexpression does not appear to produce additional mitochondrial phenotypes in otherwise wild-type cells. 60 min after transfer to dextrose, the intracellular level of Dnm1p falls below that observed in the *DNM1* control strain (Fig. [8](#F8){ref-type="fig"} *D*, relative protein level = 0.9), and branches begin to disappear from the mitochondrial network producing an intermediate mitochondrial morphology (Fig. [8](#F8){ref-type="fig"} *D*, *open squares*; and 8 *E*, *Intermediate*). At later time points, mitochondrial morphology collapses further in these cells to produce the elongated mitochondrial structures characteristic of *dnm1* null cells (Fig. [8](#F8){ref-type="fig"} *D*, *closed triangles*; and 8 *E*, *Null*). Once again, control cells containing the *DNM1* gene expressed from its own promoter maintain wild-type mitochondrial networks throughout an identical time course (Fig. [8](#F8){ref-type="fig"} *C*, *closed circles*). These results demonstrate that changes in mitochondrial morphology can be directly correlated with changes in the level of Dnm1p expression.

The Predicted GTPase Domain Is Required for Dnm1p Function in Mitochondrial Morphology Maintenance
--------------------------------------------------------------------------------------------------

Like other members of the dynamin family, the NH~2~-terminal domain of Dnm1p contains a predicted GTP-binding motif with the conserved sequence elements GSQSSGKS~42~ (Fig. [9](#F9){ref-type="fig"} *A*, *G1*), DLPG~178~ (Fig. [9](#F9){ref-type="fig"} *A*, *G3*, sequence not shown), and TKLD~247~ (Fig. [9](#F9){ref-type="fig"} *A*, *G4*, sequence not shown) ([@B9]). Although a G2 motif consisting of a conserved threonine ([@B9]) has not been experimentally defined in dynamins, Dnm1p contains a threonine at position 62 that has the potential to serve as a G2 domain (Fig. [9](#F9){ref-type="fig"} *A*). To determine whether the predicted GTP-binding motif in *DNM1* is important for function, point mutations that alter the nucleotide-binding and/or hydrolysis properties of GTPases (Fig. [9](#F9){ref-type="fig"} *A*) were introduced into a *DNM1* gene contained on a low-copy (pRU1) or high-copy (YEp213) ([@B46]) plasmid and expressed in yeast (Fig. [9](#F9){ref-type="fig"} *B*). The G1 *dnm1^K41A^* mutation is predicted to abolish nucleotide binding ([@B9]; [@B61]), the G1 *dnm1^S42N^* mutation is predicted to have reduced affinity for GTP ([@B17]; [@B27]), and the G2 *dnm1^T62A^* mutation is equivalent to a mutation in the p21^ras^ GTPase that is thought to interfere with p21^ras^ GAP binding ([@B1]; [@B11]) and with raf kinase interactions ([@B64]). A *dnm1* mutant lacking the entire NH~2~-terminal GTP-binding domain was also constructed (*dnm1^−GTPase^*). None of these mutated *dnm1* genes expressed from a low-copy (pRU1, not shown) or high-copy plasmid (YEp213) could rescue mitochondrial morphology defects in the *dnm1* null strain (Fig. [9](#F9){ref-type="fig"} *C*, *dnm1::HIS3*), suggesting that GTP binding and/or hydrolysis is required for Dnm1p function in vivo. In addition, all four mutant *dnm1* constructs induced dominant mitochondrial morphology defects when expressed from a low-copy (pRU1, not shown) or high-copy number plasmid (YEp213) in cells containing a wild-type copy of the *DNM1* gene (Fig. [9](#F9){ref-type="fig"} *D*, *hatched bars*). These mutant constructs did not cause trans-dominant mitochondrial morphology defects in cells that were also overexpressing the wild-type Dnm1 protein. (Compare *filled bars* in Fig. [9](#F9){ref-type="fig"} *E* with *hatched bars* from Fig. [9](#F9){ref-type="fig"} *D*; wild-type Dnm1p is expressed from a genomic *GAL1-DNM1* construct at a steady-state level approximately twofold that of wild-type *DNM1* cells.) The ability of all four GTP-binding domain mutations to induce mitochondrial morphology defects in wild-type cells further supports the notion that Dnm1p plays a primary role in controlling mitochondrial morphology. Moreover, these dominant phenotypes suggest that Dnm1p associates with additional cellular components required for mitochondrial morphology maintenance.

Endocytosis of FM 4-64 Occurs with Wild-Type Kinetics in dnm1Δ Cells
--------------------------------------------------------------------

Dynamin mutations have been shown to cause endocytosis defects in both *Drosophila melanogaster* and mammalian cells ([@B39]; [@B27]; [@B61]). In contrast, cells lacking *DNM1* did not exhibit defects in the internalization of FM 4-64, a lipophilic styryl dye that has been used as a marker for endocytosis in yeast ([@B63]). Wild-type and *dnm1Δ* cells were labeled with FM 4-64 for 30 min at 0°C to allow the dye to accumulate in the plasma membrane (Table [II](#TII){ref-type="table"}; Fig. [10](#F10){ref-type="fig"}, *A* and *B*). The cells were subsequently washed to remove free dye and shifted to 30°C, and the internalization of FM 4-64 was monitored over a 60-min time course. As shown in Table [II](#TII){ref-type="table"} and Fig. [10](#F10){ref-type="fig"}, the kinetics of FM 4-64 uptake in the *dnm1Δ* strain and an isogenic wild-type strain were identical. After 10 min at 30°C, the FM 4-64 signal in the plasma membrane (Table [II](#TII){ref-type="table"}, *PM*) was still visible, and small fluorescent endosome-like intermediates (*E*) began to accumulate in the cytoplasm (Fig. [10](#F10){ref-type="fig"}, *C* and *D*). After 20 min, the PM-associated signal had decreased, and the majority of FM 4-64 fluorescence was concentrated in these endosome-like compartments (Table [II](#TII){ref-type="table"}; Fig. [10](#F10){ref-type="fig"}, *E* and *F*). At the 40-min time point, the FM 4-64 signal had begun to accumulate in the vacuole membrane (Table [II](#TII){ref-type="table"}, *V*), although some punctate cytoplasmic structures were still visible (Fig. [10](#F10){ref-type="fig"}, *G* and *H*). By 60 min, the majority of FM 4-64 signal was associated with the vacuole membrane (Table [II](#TII){ref-type="table"}; Fig. [10](#F10){ref-type="fig"}, *I* and *J*). The finding that the kinetics of FM 4-64 internalization in *dnm1Δ* cells are indistinguishable from wild type indicates that Dnm1p is not required for bulk endocytosis of the plasma membrane in yeast.

Endocytosis Defects Do Not Induce Changes in Yeast Mitochondrial Morphology
---------------------------------------------------------------------------

To further examine the possibility that the mitochondrial morphology defect in *dnm1* was a secondary consequence of an endocytic defect, we examined the mitochondrial network in well-characterized yeast mutants blocked at distinct steps in endocytosis. The *end3* and *end4* mutations block the internalization step of endocytosis ([@B41]; [@B4]). *end13/vps4* does not affect internalization but does affect delivery of internalized material to the vacuole ([@B36]; [@B2]). *vps18* mutants completely lack a structure resembling the vacuole (the terminal endocytic compartment) ([@B42]), and *pan1* mutants accumulate compartments similar to early endosomes ([@B69]). We visualized mitochondrial morphology in these mutants (Fig. [11](#F11){ref-type="fig"}, *B--F*) and their isogenic wild-type parents (Fig. [11](#F11){ref-type="fig"} *A* and data not shown) and detected no defects in mitochondrial morphology. Thus, the mitochondrial morphology phenotype observed in the *dnm1* mutant is not an indirect consequence of an endocytosis defect.

Dnm1p Is Found in Punctate Structures that Colocalize with the Mitochondrial Network at the Cell Cortex
-------------------------------------------------------------------------------------------------------

The localization of Dnm1p in wild-type cells is consistent with its role in mitochondrial morphology maintenance. We performed indirect immunofluorescence studies to localize a Dnm1-HA--tagged protein (Dnm1--HA~C~p) in yeast (Fig. [12](#F12){ref-type="fig"}, *B*, *E*, *H*, and *K*). Mitochondrial networks in the same cells were simultaneously visualized with the Cox4--GFP fusion protein (Fig. [12](#F12){ref-type="fig"}, *A*, *D*, *G*, and *J*). Confocal microscopy was used to evaluate the degree of Dnm1-- HA~C~p colocalization with mitochondrial networks in merged images (Fig. [12](#F12){ref-type="fig"}, *C*, *F*, *I*, and *L*). In a wild-type strain, yeast mitochondrial networks visualized with Cox4--GFP were localized at the cell cortex and distributed evenly around the cell circumference (Fig. [12](#F12){ref-type="fig"}, *A* and *D*, green fluorescence, Cox4--GFP). In cells expressing the Dnm1--HA~C~p protein, monoclonal antibodies specific for the HA epitope (Fig. [12](#F12){ref-type="fig"} *E*, red fluorescence, CY5-conjugated secondary antibody) stained punctate structures that also localized to the cell cortex. In addition, a haze of fluorescence was observed throughout the cell, suggesting that there was also a pool of cytoplasmic Dnm1--HA~C~ protein. Dnm1--HA~C~p staining was not detected in control experiments performed in the absence of the primary anti-HA antibody (Fig. [12](#F12){ref-type="fig"} *B*). When the images in Fig. [12](#F12){ref-type="fig"}, *D* and *E*, were merged (Fig. [12](#F12){ref-type="fig"} *F*), the majority of the Dnm1--HA~C~p spots visualized with CY5 (85%) appeared on the sides of mitochondrial tubules, at mitochondrial network branch points, or at the tips of mitochondrial tubules. (Yellow areas correspond to regions where the red and green signals are superimposed.) Similar results were obtained when antibodies raised against the Dnm1 protein were used to stain wild-type cells (Fig. [12](#F12){ref-type="fig"}, *P--R*). Once again, these antibodies stained punctate structures at the cell cortex (Fig. [12](#F12){ref-type="fig"} *Q*) that colocalized with the mitochondrial network (Fig. [12](#F12){ref-type="fig"} *P*) in a merged image (Fig. [12](#F12){ref-type="fig"} *R*; 75% colocalization).

We were concerned that some of the colocalization might be coincidental since mitochondrial morphology is complex and both the mitochondrial network and Dnm1p are found at the cell periphery. For this reason, we also localized Dnm1--HA~C~p in an *mdm10* mutant strain ([@B55]) that lacks mitochondrial networks and, instead, contains one or a few giant spherical mitochondria (Fig. [12](#F12){ref-type="fig"}, *G* and *J*). A significant fraction (57%) of the Dnm1--HA~C~p fusion protein (Fig. [12](#F12){ref-type="fig"} *K*) still localized at or near the spherical mitochondria in *mdm10* cells (Fig. [12](#F12){ref-type="fig"} *L*), suggesting that these Dnm1--HA~C~p-containing structures are bound directly or indirectly to the mitochondrial compartment. In addition, a portion of the Dnm1--HA~C~p (43%) remained in punctate spots at the cortex in *mdm10* cells, indicating that Dnm1p may be localized to the cell cortex independent of the mitochondrial network.

Subcellular Localization of Dnm1p
---------------------------------

Immunoblot analysis of yeast subcellular fractions suggested that a portion of Dnm1p was associated with an enriched mitochondrial pellet. A total cell extract from a wild-type strain (JSY1238; Fig. [13](#F13){ref-type="fig"} *A*, lane *1*) was subjected to differential sedimentation to generate a P~10,000~ pellet (Fig. [13](#F13){ref-type="fig"} *A*, lane *2*) and an S~10,000~supernatant (Fig. [13](#F13){ref-type="fig"} *A*, lane *3*). Characterization of these fractions by immunoblotting with anti-Dnm1p, anti--3-PGK (cytosol), and antiporin (mitochondrial outer membrane) antisera revealed that a substantial amount of Dnm1p was either soluble or associated with a nonmitochondrial membrane fraction that could not be pelleted at 10,000 *g* (Fig. [13](#F13){ref-type="fig"} *A*, lane *3*). However, a portion of Dnm1p cofractionated with the P~10,000~ pellet, a fraction enriched in mitochondrial membranes (Fig. [13](#F13){ref-type="fig"} *A*, lane *2*). Washing the P~10,000~ pellet and sedimenting a second time at 10,000 *g* released additional Dnm1p into the supernatant, suggesting that the protein was not tightly associated with membranes in this fraction (Fig. [13](#F13){ref-type="fig"} *A*, compare washed P~10,000~ in lane *6* with the S~10,000~wash in lane *7*). Indeed, treatment of the initial P~10,000~ fraction with 0.1 M Na~2~CO~3~, pH 11.5, to release peripheral membrane proteins completely disrupted the association of Dnm1p with the membrane pellet (Fig. [13](#F13){ref-type="fig"} *G*).

The cellular distribution of Dnm1p was not dramatically affected by overexpressing wild-type Dnm1p, or expressing mutant forms of Dnm1p, in wild-type and *dnm1Δ* strains. The relative amount of Dnm1p associated with the P~10,000~ fraction during differential sedimentation did not significantly increase or decrease when an extra copy of the wild-type *DNM1* (Fig. [13](#F13){ref-type="fig"} *B*) or the mutated *dnm1^K41A^* (Fig. [13](#F13){ref-type="fig"} *C*) gene was introduced into wild-type cells on a low-copy plasmid. Similar fractionation results were obtained when low-copy plasmids harboring mutated *dnm1^K41A^* (Fig. [13](#F13){ref-type="fig"} *D*), *dnm1^S42N^*(not shown), or *dnm1^T62A^* (not shown) genes were introduced into a *dnm1Δ* strain. In addition, the Dnm1p fractionation pattern did not change significantly when differential sedimentation studies were performed on wild-type or *dnm1Δ* cells expressing the *DNM1*, *dnm1^K41A^*, *dnm1^S42N^*, and *dnm1^T62A^* genes from high-copy plasmids (data not shown). Finally, the subcellular distribution of Dnm1p in an *mdm10* mutant strain (Fig. [13](#F13){ref-type="fig"} *F*) did not differ significantly from wild type (Fig. [13](#F13){ref-type="fig"} *E*).

The fractionation studies described above did not reveal whether Dnm1p was associated with mitochondrial membranes or with other cellular membranes in the P~10,000~ pellet. In addition, these studies did not address the possibility that Dnm1p forms aggregates that nonspecifically sediment with or are trapped by membranes during centrifugation. To distinguish between these possibilities, we separated membranes in the P~10,000~pellet (Fig. [14](#F14){ref-type="fig"} *A*, lane *2*) by flotation in a sucrose density gradient (Fig. [14](#F14){ref-type="fig"}; [@B66]). As shown in Fig. [14](#F14){ref-type="fig"} *B*, the majority of Dnm1p in P~10,000~was soluble and remained at the bottom of the gradient (graph *ii*, fractions *18--20*) with the cytoplasmic protein 3-PGK (graph *iii*, fraction *20*). However, a portion of Dnm1p cofractionated with the mitochondrial outer membrane protein porin in fraction 15 (Fig. [14](#F14){ref-type="fig"} *B*, graph *ii*). The Dnm1p peak in fraction 15 was not completely coincident with marker peaks for the Golgi apparatus (graph *iv*, Mnn1p), the vacuole (graph *v*, ALP), or the plasma membrane (graph *v*, Gas1p). Although the ER marker Dol-P-Man synthase was found in two well separated peaks in the gradient (Fig. [14](#F14){ref-type="fig"} *B*, graph *iv*, peaks at fractions *7* and *15*), Dnm1p only localized with the ER peak in fraction 15. Since the porin mitochondrial marker was also found in fraction 15, and since Dnm1p colocalized with intact mitochondrial networks in indirect immunofluorescence experiments, it seems likely that Dnm1p associates with mitochondrial membranes in this fraction.

To determine whether the Dnm1p found in the initial S~10,000~ supernatant (Fig. [14](#F14){ref-type="fig"} *A*, lane *3*) was associated with additional cellular membranes, this supernatant was further fractionated at 100,000 *g* to yield S~100,000~ and P~100,000~. Although the ER (Dol-P-Man), Golgi apparatus (Mnn1p), vacuole (ALP), and plasma membrane (Gas1p) markers sedimented under these conditions and were found in the P~100,000~ pellet (Fig. [14](#F14){ref-type="fig"} *C*, lane *2*), the majority of Dnm1p was soluble and remained in the S~100,000~ supernatant along with the soluble cytoplasmic protein 3-PGK (Fig. [14](#F14){ref-type="fig"} *C*, lane *1*).

Discussion {#Discussion}
==========

The studies described here establish Dnm1p as an important regulator of mitochondrial morphology in yeast. In *dnm1* mutants, the mitochondrial membranes fail to be distributed properly at the cortex and collapse to one side of the cell. In contrast, the loss of Dnm1p function has no apparent effect on the morphology and distribution of other cytoplasmic organelles, including nuclei, the endoplasmic reticulum, the Golgi apparatus, and vacuoles. Despite their unusual morphology, *dnm1* mitochondria are able to generate a membrane potential and import a Cox4--GFP marker protein into the mitochondrial matrix, suggesting that basic organelle functions are not severely impaired. Unlike other yeast mitochondrial morphology mutants, which rapidly lose mtDNA and exhibit defects in mitochondrial inheritance ([@B24]), *dnm1* mitochondria retain their mtDNA and are efficiently transported into buds during division. Together, our results indicate that Dnm1p plays a very specific role in defining the shape and distribution of yeast mitochondrial membranes.

The immunolocalization of Dnm1p in intact cells is consistent with a role for this protein in controlling mitochondrial morphology and distribution. In wild-type cells, Dnm1p is found in punctate structures at the cell cortex that colocalize with branch points in the mitochondrial network and the tips and sides of mitochondrial tubules. A portion of these Dnm1p-containing structures remain associated with the spherical mitochondria found in the *mdm10* mutant, suggesting that Dnm1p associates directly or indirectly with the organelle. This interpretation is supported by the observation that a small amount of Dnm1p reproducibly fractionates with mitochondrial membranes in sucrose density gradients. The proportion of total cellular Dnm1p associated with mitochondria in these gradients (and in the differential sedimentation studies) may be underrepresented because of fragmentation of the mitochondrial network during cell lysis. Our subcellular fractionation studies suggest that there is also a large cytoplasmic pool of Dnm1p. Although it is tempting to speculate that cycles of GTP binding and hydrolysis regulate the reversible association of Dnm1p with mitochondria, we did not detect differences in the subcellar distribution of wild-type and GTPase mutant Dnm1 proteins. However, we cannot rule out the possibility that the GTP-bound form of Dnm1p associates with mitochondrial membranes since we were unable to make mutations predicted to bind but not hydrolyze GTP. Further experiments are needed to determine the effect of GTP binding and hydrolysis on Dnm1p--mitochondrial interactions.

A deletion mutation and three different amino acid substitutions in the predicted GTP-binding domain of Dnm1p failed to rescue mitochondrial morphology defects in a *dnm1* strain. Two of these mutations were generated in the G1 motif and are predicted to either reduce the affinity of the protein for both GTP and GDP (*dnm1^K41A^*; [@B9]; [@B61]), or are predicted to have reduced affinity for GTP (*dnm1^S42N^*; Feig et al., 1988; [@B27]). The failure of these mutant proteins to rescue the *dnm1* mutant phenotype demonstrates that a functional Dnm1p GTPase domain is required for maintenance of the mitochondrial network in yeast. In support of this interpretation, preliminary studies in our lab indicate that a bacterially-expressed form of wild-type Dnm1p can bind and hydrolyze GTP in an in vitro assay (Brisch, E., and J.M. Shaw, unpublished data).

The Dnm1p GTPase domain mutations also cause dominant mitochondrial morphology defects in wild-type cells. These defects can be completely rescued by overexpressing the wild-type Dnm1 protein in the same strain. Analogous mutations in mammalian dynamin ([@B27]; [@B61]; [@B13]) and the yeast dynamin-like protein Vps1p ([@B62]) cause similar dominant negative defects in endocytosis and vacuolar protein sorting, respectively. In the case of mammalian dynamin, the dominant negative endocytosis phenotype is thought to be related to the self assembly properties of this protein ([@B67]). It is possible that coassembly of mutant and wild-type Dnm1 proteins produces oligomers or higher order structures that cannot be disassembled and block the function of Dnm1p in wild-type cells. Alternatively, mutant Dnm1 proteins could produce dominant phenotypes in wild-type cells by titrating out other physiologically important binding partners. Studies are currently underway to determine whether Dnm1p homooligomerizes and/or interacts with additional protein-binding partners.

The GTPase domains of many proteins include a G2 motif with a conserved threonine residue ([@B9]). In p21^ras^, this threonine interacts directly with a catalytic Mg^2+^ ion and the γ-phosphate of GTP ([@B37]). p21^ras^ mutations that affect this residue prevent GTP-dependent interactions with the p21^ras^-GAP and the raf kinase ([@B1]; [@B11]; [@B9]; [@B64]). Although dynamins contain a conserved threonine 20 residues downstream of the G1 motif, this region has not been defined as a G2 motif. In this study, we show that a T62A mutation in Dnm1p fails to rescue mitochondrial morphology defects in *dnm1* cells and induces the mitochondrial network to collapse in wild-type cells. These results demonstrate that threonine 62 constitutes a bona fide G2 element in the Dnm1p GTPase domain. In keeping with the nomenclature originally used to define the domain structure of GTPases, we have renamed the conserved threonine in Dnm1p "G2," and the more carboxy-terminal elements G3 and G4 (see Fig. [9](#F9){ref-type="fig"} *A*).

An earlier study suggested that endosomal trafficking was delayed two- to threefold in cells lacking the *DNM1* gene ([@B19]). Although we observed mitochondrial morphology defects in the [@B19] *dnm1Δ* mutant, we did not detect endocytosis defects in our *dnm1Δ* strain. The different endocytic phenotypes observed for these two *dnm1Δ* mutants may reflect differences in the strain backgrounds or assays used by the two labs. It is also formally possible that the Dnm1 protein has dual roles in endosomal trafficking and mitochondrial morphology maintenance. Alternatively, endosomal trafficking defects in the [@B19] strain may be a secondary consequence of defects in mitochondrial morphology. In this study, we showed that mitochondrial morphology is wild type in five mutants blocked at distinct steps in the endocytic pathway. These data indicate that defects in endocytosis do not lead to secondary defects in mitochondrial membrane shape or distribution and provide further support that the mitochondrial morphology defects observed in *dnm1* mutant cells are a direct result of the loss of Dnm1 protein function.

Exactly how the Dnm1 GTPase acts to control mitochondrial morphology and distribution in cells is not yet clear. It is possible that assembly of Dnm1p-containing structures at specific sites on the mitochondrial double membrane is responsible for initiating or regulating the formation of mitochondrial tubules or branches. Our TEM analysis of *dnm1* mitochondria suggests that some tubular and branched membranes are still present in these organelles. Thus, while Dnm1p could play a role in generating mitochondrial tubules and branches, it is probably not the only molecule required for this process. An alternative possibility is that Dnm1p-containing structures are required to spread out and anchor portions of the mitochondrial network at the cell periphery. This latter model is consistent with the localization of Dnm1p to discrete patches at the cell cortex, the colocalization of these Dnm1p patches with the mitochondrial network, and the observation that the peripheral mitochondrial reticulum collapses to a restricted region of the cell cortex when Dnm1p is absent. Finally, it is also possible that, like mammalian dynamin, the Dnm1p GTPase plays a role in regulating membrane scission events at discrete positions on the mitochondrial reticulum. These models are not mutually exclusive, and some combination of these events could be simultaneously regulated by Dnm1p in vivo. Regardless of the mechanism of Dnm1p function, our results indicate that this protein plays a central role in controlling the shape and distribution of mitochondrial membranes.

A human gene closely related to Dnm1p was recently identified and termed variously DVLP (Dnm1p/Vps1p-like protein; [@B53]), Dymple (dynamin family member proline-rich carboxy-terminal domain less; [@B32]), DLP1 (dynamin-like protein 1; [@B71]), and DRP1 (dynamin-related protein 1; see related article by Smirnova et al., 1998; [@B29]). Interestingly, the transient expression of Drp1 mutant proteins with altered GTP-binding domains causes aggregation of mitochondrial tubules in COS-7 cells but does not affect the morphology of other organelles or the transport of proteins through the secretory and endocytic pathways (see related article by Smirnova et al., 1998). While it is not yet clear whether mammalian Drp1 is a functional homologue of *S*. *cerevisiae* Dnm1p, the ability of mutant Drp1 to induce mitochondrial phenotypes in mammalian cells raises the intriguing possibility that Dnm1p-like GTPases play an evolutionarily conserved role in regulating mitochondrial distribution and morphology.

Dnm1p joins a growing family of dynamin-related proteins that localize to different organelles in mammals ([@B23]; Jones et al., 1998; [@B71]), yeast ([@B45]; [@B30]; [@B21]), and plants (Gu and Verma, 1996; [@B38]). Future studies should reveal the role these different GTPases play in remodeling cellular membranes.
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Yeast Strains

  Strain        Genotype[\*](#TFI-150){ref-type="table-fn"}                                           Source/Reference
  ---------- -- ---------------------------------------------------------------------------------- -- ------------------
  FY10          *MATα ura3-52 leu2Δ1*                                                                 [@B70]
  FY250         *MATα ura3-52 leu2Δ1 his3Δ200 trp1Δ63*                                                [@B70]
  JSY1236       *MATa ura3-52 mdm29-1*                                                                This study
  JSY1943       *MATa ura3-52 leu2Δ1 his3Δ200 mdm29-2*                                                This study
  MS3031        *MATα ura3-52 ade2-101 leu2-3,112 his3Δ200 dnm1::HIS3*                                [@B19]
  JSY1238       *MATa ura3-52 leu2Δ1 his3Δ200*                                                        This study
  JSY1361       *MATa ura3-52 leu2Δ1 his3Δ200 dnm1::HIS3*                                             This study
  JSY1542       *MATa ura3-52 leu2Δ1 his3Δ200 DNM1-HA[~c~]{.smallcaps}*                               This study
  JSY1678       *MATa ura3-52 leu2Δ1 his3Δ200 GAL1-DNM1*                                              This study
  JSY1781       *MATa/MATα ura3-52/ura3-52 leu2Δ1/leu2Δ1 his3Δ200/HIS3 DNM1-HA~c~  /DNM1-HA ~c~*      This study
  JSY1729       *MATα his3 leu2 mdm10::URA3 DNM1-HA[~c~]{.smallcaps}*                                 This study
  SEY6210       *MATα leu2-3,112 his3Δ200 ura3-52 trp1-Δ901 lys2-801 suc2-Δ9 GAL*                     S. Emr
  RH268-1C      *MATa his4 leu2 ura3 bar1-1 end4*                                                     [@B41]
  RH266-1D      *MATa ura3 leu2 his4 bar1-1 end3*                                                     [@B41]
  JSR18Δ1       SEY6210; *vps18Δ1::TRP1*                                                              [@B42]
  MBY3          SEY6210; *vps4::TRP1*                                                                 [@B2]
  BWY18         *MATa leu2-3,112 his3Δ200 ura3-52 trp1-Δ901 pan1-20*                                  [@B69]
  JSY1914       *MATα ura3 his3*                                                                      This study
  JSY1916       *MATa ura3 his3 mdm10::URA3*                                                          This study

All of the JSY strains used in this study are isogenic to FY10 ([@B70]) except JSY1914 and JSY1916, which were generated by crossing MYY503 (*mdm10::URA3*; [@B55]) into the FY background, and JSY1729, which was generated by crossing MYY503 with an FY strain containing *DNM1-HA~c~*.  

![Mitochondrial morphology in wild-type (*DNM1*) and *dnm1Δ* mutant strains. Mitochondrial morphology in the *DNM1* (JSY1238, *left*) and *dnm1Δ* (JSY1361, *right*) strains were visualized using a matrix-targeted form of the green fluorescent protein (Cox4--GFP). Buds are in the upper left portion of each panel. Bar, 2 μm.](JCB9805048.f1){#F1}

![Collapsed *dnm1Δ* mitochondria retain mtDNA nucleoids. *DNM1* (JSY1238, *A* and *B*) and *dnm1Δ* (JSY1361, *C* and *D*) strains labeled with Cox4--GFP (*A* and *C*) to visualize mitochondrial compartments and DAPI (*B* and *D*) to visualize nuclei (*N*) and mtDNA (*B* and *D*, *white arrows*). Buds are in the upper right portion of each panel. Bar, 2 μm.](JCB9805048.f2){#F2}

![Dnm1p colocalizes with the yeast mitochondrial network. Wild-type (JSY1781, *A--F*; JSY1238, *M--R*) or *mdm10* mutant (JSY1729, *G--L*) cells expressing Dnm1-- HA~C~p (*A--L*) or wild-type Dnm1p (*M--R*) were fixed and incubated with no primary antibody (*A--C*, *G--I*, and *M--O*), anti-HA antibody (*D--F* and *J--L*), or anti-Dnm1p^412--757^ antibody (*P--R*). A CY5-conjugated secondary antibody (red fluorescence in *B*, *E*, *H*, *K*, *N*, and *Q*) was used to visualize the Dnm1--HA[~c~]{.smallcaps} and Dnm1 proteins. Mitochondrial networks were visualized by expressing the matrix-targeted Cox4--GFP protein (green fluorescence in *A*, *D*, *G*, *J*, *M*, and *P*) in the same cells. The merged CY5 and GFP images are shown in *C*, *F*, *I*, *L*, *O*, and *R*. Bar, 2 μm.](JCB9805048.f12){#F12}

![Transmission electron microscopy of *DNM1* and *dnm1Δ* cells. (*A*) Mitochondrial profiles (*black arrows*) in *DNM1* cells (JSY1238) are uniformly dispersed in the peripheral cytoplasm and contain visible cristae. (*B* and *C*) Mitochondrial profiles (*black arrows*) in *dnm1Δ* cells (JSY1361) contain normal cristae but appear as enlarged tubules clustered at one side of the cell. Bar, 500 nm.](JCB9805048.f3){#F3}

![ER morphology is wild type in *dnm1Δ* cells. DIC (*A* and *D*), DAPI (*B* and *E*), and indirect immunofluorescence images (*C* and *F*) of *DNM1* (JSY1238, *A--C*) and *dnm1Δ* (JSY1361, *D--F*) cells stained with anti-Kar2p antiserum. Buds are in the upper portion of each panel. White arrows in *C* and *F* mark the perinuclear ER stained with anti-Kar2p antiserum. Bar, 2 μm.](JCB9805048.f4){#F4}

![Golgi apparatus morphology is wild type in *dnm1Δ* cells. Confocal microscopy images of *DNM1* (JSY1238, *A* and *B*) and *dnm1Δ* (JSY1361, *C* and *D*) cells labeled with the peripheral Golgi membrane marker, Sec7p-EGFP. White arrows in *A* and *C* indicate magnified cells shown in *B* and *D*, respectively. Bars, 2 μm.](JCB9805048.f5){#F5}

![Vacuole morphology is wild type in *dnm1Δ* cells. Differential interference contrast (*A* and *C*) and fluorescence images (*B* and *D*) of *DNM1* (JSY1238, *A* and *B*) and *dnm1Δ* (JSY1361, *C* and *D*) cells labeled with the vacuole membrane--specific styryl dye, FM 4-64. Bar, 2 μm.](JCB9805048.f6){#F6}

![Actin and tubulin cytoskeleton organization are wild type in *dnm1Δ* cells. Differential interference contrast images (*A*, *C*, *E*, and *G*), rhodamine-phalloidin--stained actin (*B* and *D*), and antitubulin staining (*F* and *H*) of *DNM1* (JSY1238; *A*, *B*, *E*, and *F*) and *dnm1Δ* (JSY1361; *C*, *D*, *G*, and *H*) cells. Buds are in the upper portion of each panel. Bar, 2 μm.](JCB9805048.f7){#F7}

###### 

Mitochondrial morphology changes in response to changes in *DNM1* gene expression. Null (*closed triangles*), intermediate (*open squares*), and wild-type (*closed circles*) mitochondrial morphologies were quantified by DiOC~6~ staining in cells containing a single genomic copy of the wild-type *DNM1* (JSY1238; *A* and *C*) or *GAL1-DNM1* (JSY1678; *B* and *D*) gene. (*A*) *DNM1* cells transferred from dextrose to galactose. (*B*) *GAL1-DNM1* cells transferred from dextrose to galactose. (*C*) *DNM1* cells transferred from galactose to dextrose. (*D*) *GAL1-DNM1* cells transferred from galactose to dextrose. The amount of Dnm1p expressed in the *GAL1-DNM1* strain relative to the *DNM1* strain is indicated for selected time points below graphs *B* and *D*. (WT = *DNM1* = 1.0; *U*, undetected). (*E*) Representative examples of Null (*closed triangles*), intermediate (*open squares*), and WT (*DNM1*; *closed circles*) mitochondrial morphologies. Buds are in the upper portion of each panel. Bar, 2 μm.
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###### 

GTPase domain mutations in *DNM1* cause dominant interfering phenotypes in vivo. (*A*) The position of the four, NH~2~-terminal GTP-binding consensus elements (G1--G4) conserved among different dynamin family members is shown. The point mutations (*arrows*) and the deletion mutation (*bracket*) used in this study are indicated. The G1 *dnm1^K41A^* mutation and the deletion mutation are predicted to abolish nucleotide binding, the G1 *dnm1^S42N^* mutation is predicted to bind GDP more tightly than GTP, and the G2 *dnm1^T62A^* mutation is equivalent to a mutation in the ras GTPase that abolishes effector interactions (see text for references). (*B*) Endogenous and plasmid expression levels of wild-type and GTPase mutant forms of Dnm1p. A total cell extract from each strain was analyzed by Western blotting with anti-Dnm1p antiserum. Lane *1*, *DNM1* (JSY1238); lane *2*, *dnm1Δ* (*dnm1:: HIS3*, JSY1361); lane *3*, *dnm1Δ* + pRU1-*dnm1^K41A^* (*CEN*, single copy); lane *4*, *dnm1Δ* + YEP213-*dnm1^K41A^* (2μ, multicopy); lane *5*, *dnm1Δ* + pRU1-*dnm1^T62A^*; lane *6*, *dnm1Δ* + YEP213-*dnm1^T62A^*; lane *7*, *dnm1Δ* + pRU1-*dnm1^S42N^*; lane *8*, *dnm1Δ* + YEP213-*dnm1^S42N^*. The black arrow marks the full-length form of wild-type and mutant Dnm1 proteins. Dnm1p breakdown products (*bracket*) accumulate in cells overexpressing Dnm1 proteins. Expression of the *dnm1*/-GTPase deletion mutant protein from the pRU1 and YEP213 plasmids was similar to that shown for the other mutants (not shown). (*C*) DiOC~6~ staining was used to quantify the ability of a multicopy vector alone (YEP213; *LEU2*), or the vector containing wild-type (*DNM1*) or mutated (*dnm1*/K41A, *dnm1*/T62A, *dnm1*/S42N, *dnm1*/-GTPase) forms of the *DNM1* gene to restore wild-type mitochondrial morphology in *dnm1::HIS3* null cells (JSY1361). The percentage of cells with wild-type mitochondrial morphology is indicated in each case (*open bars*). (*D*) The ability of the constructs described in *C* to induce mitochondrial morphology phenotypes in a wild-type *DNM1* strain (JSY1238) was quantified by DiOC~6~ staining. The percentage of cells with wild-type mitochondrial morphology is indicated in each case (*hatched bars*). (*E*) The mutant constructs described in *C* (*dnm1*/K41A, *dnm1*/T62A, *dnm1*/S42N, and *dnm1*/-GTPase) failed to induce mitochondrial morphology defects in cells overexpressing Dnm1p from a genomic *GAL1-DNM1* gene (JSY1678) (*closed bars*; overexpressed Dnm1p levels are approximately twofold that of the wildtype *DNM1* strain). The dominant interfering phenotypes caused by these mutations in a strain expressing Dnm1p at wild-type levels (*D*; *DNM1*, JSY1238; *hatched bars*) are shown for comparison.
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###### 

Kinetics of FM 4-64 Internalization

                                                           FM 4-64 Localization                                          
  ---------------------------------------- -- --------- -- ---------------------- -- -------------- -- -------------- -- --------------
  *min*                                                                                                                  
   0[\*](#TFII-150){ref-type="table-fn"}      WT           50/50 (100%)               0/50 (0%)         0/50 (0%)         0/50 (0%)
                                              *dnm1Δ*      50/50 (100%)               0/50 (0%)         0/50 (0%)         0/50 (0%)
  10                                          WT            0/68 (0%)                68/68 (100%)       0/68 (0%)         0/68 (0%)
                                              *dnm1Δ*       0/55 (0%)                55/55 (100%)       0/55 (0%)         0/55 (0%)
  20                                          WT            0/67 (0%)                67/67 (100%)       0/67 (0%)         0/67 (0%)
                                              *dnm1Δ*       0/58 (0%)                58/58 (100%)       0/58 (0%)         0/58 (0%)
  40                                          WT            0/56 (0%)                 0/56 (0%)        56/56 (100%)       0/56 (0%)
                                              *dnm1Δ*       0/50 (0%)                 0/50 (0%)        50/50 (100%)       0/50 (0%)
  60                                          WT            0/57 (0%)                 0/57 (0%)         0/57 (0%)        57/57 (100%)
                                              *dnm1Δ*       0/60 (0%)                 0/60 (0%)         0/60 (0%)        60/60 (100%)

*PM*, plasma membrane; *E*, endosome-like intermediate; *V*, vacuole.  

0 min time point scored after incubation and wash performed at 0°C. Remaining time points were scored during the 30°C chase (see text).  

![Kinetics of FM 4-64 internalization. *DNM1* (JSY1238) and *dnm1Δ* (JSY1361) cells grown in YPD medium were labeled with FM 4-64 for 30 min at 0°C, washed, and chased in fresh medium at 30°C for 60 min. Aliquots removed at 0 (*A* and *B*), 10 (*C* and *D*), 20 (*E* and *F*), 40 (*G* and *H*), and 60 (*I* and *J*) min were scored for FM 4-64 distribution (see Table [II](#TII){ref-type="table"}) and photographed. Representative differential interference contrast (*A*, *C*, *E*, *G*, and *I*) and fluorescence (*B*, *D*, *F*, *H*, and *J*) images are shown for the *dnm1Δ* strain and were identical to those observed in wild type. Bar, 2 μm.](JCB9805048.f10){#F10}

![Mitochondrial morphology is wild type in mutants that block endocytosis. Mitochondrial morphology was visualized with Cox4--GFP in wild-type (*A*), *end3* (*B*), *end4* (*C*), *vps4* (*D*), *vps18* (*E*), and *pan1* (*F*) cells under conditions that produce an endocytosis defect in the mutants. The wild-type mitochondrial morphology observed in *A* was also observed in \>95% of the mutant cells. Buds are in the upper portion of each panel. Bar, 2 μm.](JCB9805048.f11){#F11}

![Distribution of Dnm1p in wild-type and mutant yeast cells after differential sedimentation. Yeast cells were spheroplasted, lysed, and sedimented at 1,500 *g* to remove unlysed cells and debris. The soluble extracts were sedimented at 10,000 *g* generating (lane *1*) extract, (lane *2*) P~10,000~ (contains mitochondria), and (lane *3*) S~10,000~. The P~10,000~ pellet was resuspended and sedimented again at 1,500 *g* to remove aggregates and debris generating (lane *4*) P~1,500~ and (lane *5*) S~1,500~. S~1,500~ was spun at 10,000 *g* generating (lane *6*) washed P~10,000~ and (lane *7*) S~10,000~ wash. Fractions (2 μg protein) were separated by SDS-PAGE and analyzed by Western blotting with anti-Dnm1p, anti--3-PGK (cytoplasm), and antiporin (mitochondria) serum. Strains: (*A*) *DNM1* (JSY1238), (*B*) *DNM1* + pRU1-*DNM1*, (*C*) *DNM1* + pRU1- *dnm1^K41A^*, (*D*) *dnm1Δ* (JSY1361) + pRU1-*dnm1^K41A^*, (*E*) *MDM10* (JSY1914), (*F*) *mdm10Δ* (JSY1916). (*G*) P~10,000~ pellets (*M*) containing mitochondria were treated to dissociate peripheral membrane proteins (0.1 M Na~2~CO~3~) or solubilize integral membrane proteins (1% Triton X-100), separated into pellet (*P*) and supernatant (*S*) fractions, and analyzed by SDS-PAGE and Western blotting with anti-Dnm1p, anti--3-PGK, and antiporin serum. The release of soluble cytochrome *b* ~2~ and the peripheral F~1~β ATPase subunit into the supernatant fraction after 0.1 M Na~2~CO~3~treatment was confirmed by Western blotting (data not shown).](JCB9805048.f13){#F13}

###### 

Elution profile of Dnm1p and organelle membrane markers after sucrose density fractionation of P~10,000~ from wild-type cells. (*A*) (lane *1*) Extract, (lane *2*) P~10,000~, and (lane *3*) S~10,000~ fractions were generated and analyzed as described in the legend to Fig. [13](#F13){ref-type="fig"}. (*B*) The P~10,000~ pellet from *A* was resuspended in 60% sucrose and loaded on the bottom of a 35--60% sucrose gradient. The gradient was spun to equilibrium and fractionated, and equal volumes of each fraction were analyzed by Western blotting and densitometry. Results are expressed as the percent total signal per fraction. Density (g/ml); protein (μg/ml). Fraction 1 is the top of the gradient and fraction 20 is the gradient pellet. The dotted line transects fraction 15 in each graph. (*C*) S~10,000~ supernatant from *A* was spun at 100,000 *g* and equivalent volumes of the resulting S~100,000~ (lane *1*) and P~100,000~ (lane *2*) fractions were analyzed by SDS-PAGE and Western blotting with anti-Dnm1p, anti-- 3-PGK, antiporin, anti--Dol-P-Man (endoplasmic reticulum), anti- Mnn1p (Golgi apparatus), anti-ALP (vacuole), and anti-Gas1p (plasma membrane) serum. The asterisk (\*) marks a soluble, ALP breakdown product in the vacuole lumen that is partially released during fractionation ([@B56]; [@B65]).
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